Related Experiment Video
Updated: Oct 21, 2025

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
Sulfa-induced acute eosinophilic pneumonia
Faria Nasim1, Jose Antony Paul1, Jennifer Boland-Froemming2
1Division of Pulmonary and Critical Care Medicine, University of Maryland, Baltimore, MD, USA.
Severe acute eosinophilic pneumonia (AEP) linked to sulfa drugs like sulfamethoxazole and sulfasalazine was observed in adolescents. This drug-induced lung injury required intensive care, with some patients needing lung transplants.
Area of Science:
- Pulmonology
- Toxicology
- Pharmacology
Background:
- Acute eosinophilic pneumonia (AEP) is a rare interstitial lung disease.
- Medication-induced lung injury is an important differential diagnosis for AEP.
Observation:
- Three adolescent cases of severe AEP secondary to sulfa medications (sulfamethoxazole, sulfasalazine) are presented.
- Patients exhibited fever, bilateral pulmonary infiltrates, and peripheral eosinophilia after 1-3 weeks of sulfa drug use.
- Steroid treatment was ineffective in all cases.
Findings:
- Histopathology revealed acute and organizing diffuse alveolar damage with eosinophilic infiltration in lung biopsies and explants.
- One patient required extracorporeal membrane oxygenation and prolonged mechanical ventilation.
- Two patients underwent successful lung transplantation.
Implications:
- This series highlights the clinical features of sulfa-induced AEP in adolescents.
- Early recognition and cessation of the offending sulfa medication are crucial.
- Severe cases may necessitate advanced respiratory support and lung transplantation.
Related Concept Videos
Acute Pyelonephritis I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia II: Pathophysiology
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

